Atlas Trials

Safety Study of DIPG Treatment With Autologous Dendritic Cells Pulsed With Lysated Allegenic Tumor Lines

Clinical trial NCT02840123 · UNKNOWN

Trial details

NCT number
NCT02840123
Sponsor
Fundació Sant Joan de Déu
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Diffuse Intrinsic Pontine Glioma
Start date
2016-06-01
Primary completion
2019-03-01
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.